Scholarlink

Background <p>Recent proteomic studies have documented that Long COVID in adults is characterized by a pro-inflammatory signature with thromboinflammation. However, if similar events happen also in children with Long COVID has never been investigated.</p> Methods <p>We performed an extensive protein analysis of blood plasma from pediatric patients younger than 19 years of age Long COVID and a control group of children with acute COVID-19, MIS-C, and healthy controls resulted similar for sex distribution and age. Children were classified as Long COVID if symptoms persisted for at least 8 weeks since the initial infection, negatively impacted daily life and could not be explained otherwise.</p> Results <p>112 children were included in the study, including 34 children fulfilling clinical criteria of Long COVID, 32 acute SARS-CoV-2 infection, 27 MIS-C and 19 healthy controls. Compared with controls, pediatric Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a. A Machine Learning model based on proteomic profile was able to identify LC with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.</p> Conclusions <p>Pediatric Long COVID patients have a well distinct blood protein signature marked by increased ongoing general and endothelial inflammation, similarly as happens in adults.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>Pediatric Long COVID has a distinct blood protein signature marked by increased ongoing general and endothelial inflammation.</p> </ItemContent> <ItemContent> <p>This is the first study studying and documenting proinflammatory profile in blood samples of children with long COVID.</p> </ItemContent> <ItemContent> <p>Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a.</p> </ItemContent> <ItemContent> <p>A proteomic profile was able to identify Long COVID with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.</p> </ItemContent> <ItemContent> <p>These findings may inform development of future diagnostic tests.</p> </ItemContent> </UnorderedList></p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls

  • 期刊论文

  • 发表日期：

    2025年1月24日

查看全文
  • Danilo Buonsenso,
  • Nicola Cotugno,
  • Donato Amodio,
  • Giuseppe Rubens Pascucci,
  • Gabriele Di Sante,
  • Chiara Pighi,
  • Elena Morrocchi,
  • Alessandro Pucci,
  • Giulio Olivieri,
  • Nicole Colantoni,
  • Lorenza Romani,
  • Arianna Rotili,
  • Alessia Neri,
  • Rosa Morello,
  • Michela Sali,
  • Adriana Tremoulet,
  • Francesca Raffaelli,
  • Giuseppe Zampino,
  • Paolo Rossi,
  • Piero Valentini,
  • Paolo Palma

摘要

Background

Recent proteomic studies have documented that Long COVID in adults is characterized by a pro-inflammatory signature with thromboinflammation. However, if similar events happen also in children with Long COVID has never been investigated.

Methods

We performed an extensive protein analysis of blood plasma from pediatric patients younger than 19 years of age Long COVID and a control group of children with acute COVID-19, MIS-C, and healthy controls resulted similar for sex distribution and age. Children were classified as Long COVID if symptoms persisted for at least 8 weeks since the initial infection, negatively impacted daily life and could not be explained otherwise.

Results

112 children were included in the study, including 34 children fulfilling clinical criteria of Long COVID, 32 acute SARS-CoV-2 infection, 27 MIS-C and 19 healthy controls. Compared with controls, pediatric Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a. A Machine Learning model based on proteomic profile was able to identify LC with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.

Conclusions

Pediatric Long COVID patients have a well distinct blood protein signature marked by increased ongoing general and endothelial inflammation, similarly as happens in adults.

Impact

Pediatric Long COVID has a distinct blood protein signature marked by increased ongoing general and endothelial inflammation.

This is the first study studying and documenting proinflammatory profile in blood samples of children with long COVID.

Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines CXCL11, CXCL1, CXCL5, CXCL6, CXCL8, TNFSF11, OSM, STAMBP1a.

A proteomic profile was able to identify Long COVID with an accuracy of 0.93, specificity of 0.86 and sensitivity of 0.97.

These findings may inform development of future diagnostic tests.